A multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastomaT.E. Merchant, Amar Gajjar, David L. Ashley et al.|International Journal of Radiation Oncology*Biology*Physics|2003Cited by 17